Literature DB >> 28326465

PET-CT evaluation of amyloid systemic involvement with [18F]-florbetaben in patient with proved cardiac amyloidosis: a case report.

Dario Genovesi1, Giuseppe Vergaro2, Michele Emdin2, Assuero Giorgetti3, Paolo Marzullo3.   

Abstract

BACKGROUND: One of the most frequent disorders which lead to cardiac amyloidosis is transthyretin-related amyloidosis (ATTR). Some PET radio-pharmaceuticals for the detection of beta-amyloid deposits within the brain have shown to be able to detect also cardiac amyloid deposits. We present a case of a man with ATTR studied with [18F]-florbetaben PET-CT.
RESULTS: Total-body scan showed a moderate uptake in the bone marrow, especially in correspondence of the vertebral column, while no significant myocardial uptake was present. Cardiac-focused scans showed low mean cardiac SUV values confirming the absence of significant myocardial uptake. Brain scan showed a significant cortical brain uptake of the radio-pharmaceutical more evident in correspondence of frontal and temporal lobes.
CONCLUSIONS: Distinct subtypes of amyloidosis show different uptake of the radiotracer. Brain amyloid deposition in the presence of a systemic disease could not be caused by the same amyloid precursor.

Entities:  

Keywords:  PET/CT imaging; [18F]-florbetaben; cardiac amyloidosis; radiopharmaceuticals

Mesh:

Substances:

Year:  2017        PMID: 28326465     DOI: 10.1007/s12350-017-0856-5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  10 in total

1.  Imaging cardiac amyloidosis: a pilot study using ¹⁸F-florbetapir positron emission tomography.

Authors:  Sharmila Dorbala; Divya Vangala; James Semer; Christopher Strader; John R Bruyere; Marcelo F Di Carli; Stephen C Moore; Rodney H Falk
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-20       Impact factor: 9.236

2.  F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain.

Authors:  Wei Zhang; Shunichi Oya; Mei-Ping Kung; Catherine Hou; Donna L Maier; Hank F Kung
Journal:  Nucl Med Biol       Date:  2005-11       Impact factor: 2.408

3.  Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines.

Authors:  Jean D Sipe; Merrill D Benson; Joel N Buxbaum; Shu-Ichi Ikeda; Giampaolo Merlini; Maria J M Saraiva; Per Westermark
Journal:  Amyloid       Date:  2016-11-24       Impact factor: 7.141

4.  Cardiac Amyloid Imaging with 18F-Florbetaben PET: A Pilot Study.

Authors:  W Phillip Law; William Y S Wang; Peter T Moore; Peter N Mollee; Arnold C T Ng
Journal:  J Nucl Med       Date:  2016-06-15       Impact factor: 10.057

5.  18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study.

Authors:  Mi-Ae Park; Robert F Padera; Anthony Belanger; Shipra Dubey; David H Hwang; Vikas Veeranna; Rodney H Falk; Marcelo F Di Carli; Sharmila Dorbala
Journal:  Circ Cardiovasc Imaging       Date:  2015-08       Impact factor: 7.792

6.  Amyloid in bone marrow smears of patients affected by multiple myeloma.

Authors:  Fara Petruzziello; Pio Zeppa; Lucio Catalano; Immacolata Cozzolino; Giuseppe Gargiulo; Pellegrino Musto; Fiorella D'Auria; Vincenzo Liso; Rita Rizzi; Nadia Caruso; Catello Califano; Eugenio Piro; Maurizio Musso; Vincenza Bonanno; Antonietta Pia Falcone; Salvatore Tafuto; Francesco Di Raimondo; Michelino De Laurentiis; Fabrizio Pane; Lucio Palombini; Bruno Rotoli
Journal:  Ann Hematol       Date:  2009-11-06       Impact factor: 3.673

7.  M-mode and two-dimensional echocardiographic features in cardiac amyloidosis.

Authors:  A G Siqueira-Filho; C L Cunha; A J Tajik; J B Seward; T T Schattenberg; E R Giuliani
Journal:  Circulation       Date:  1981-01       Impact factor: 29.690

8.  Is 18F-flutemetamol PET/CT able to reveal cardiac amyloidosis?

Authors:  Renaud Lhommel; Christine Sempoux; Adrian Ivanoiu; Lucienne Michaux; Bernhard Gerber
Journal:  Clin Nucl Med       Date:  2014-08       Impact factor: 7.794

9.  Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations.

Authors:  Per Westermark; Joakim Bergström; Alan Solomon; Charles Murphy; Knut Sletten
Journal:  Amyloid       Date:  2003-08       Impact factor: 7.141

10.  Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

Authors:  Julian D Gillmore; Mathew S Maurer; Rodney H Falk; Giampaolo Merlini; Thibaud Damy; Angela Dispenzieri; Ashutosh D Wechalekar; John L Berk; Candida C Quarta; Martha Grogan; Helen J Lachmann; Sabahat Bokhari; Adam Castano; Sharmila Dorbala; Geoff B Johnson; Andor W J M Glaudemans; Tamer Rezk; Marianna Fontana; Giovanni Palladini; Paolo Milani; Pierluigi L Guidalotti; Katarina Flatman; Thirusha Lane; Frederick W Vonberg; Carol J Whelan; James C Moon; Frederick L Ruberg; Edward J Miller; David F Hutt; Bouke P Hazenberg; Claudio Rapezzi; Philip N Hawkins
Journal:  Circulation       Date:  2016-04-22       Impact factor: 29.690

  10 in total
  5 in total

1.  Cardiac amyloidosis imaging with amyloid positron emission tomography: A systematic review and meta-analysis.

Authors:  Yong Joong Kim; Sejin Ha; Yong-Il Kim
Journal:  J Nucl Cardiol       Date:  2018-07-18       Impact factor: 5.952

2.  [Value of (11)C-PiB PET/MRI in the evaluation of organ involvement in primary systemic light chain amyloidosis].

Authors:  Y D Wang; Y Y Yang; Y Y Wu; C Y Sun
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2022-04-14

3.  Cardiac amyloidosis characterization by kinetic model fitting on [18F]florbetaben PET images.

Authors:  M F Santarelli; D Genovesi; M Scipioni; V Positano; B Favilli; A Giorgetti; G Vergaro; L Landini; M Emdin; P Marzullo
Journal:  J Nucl Cardiol       Date:  2021-04-16       Impact factor: 3.872

4.  Extracardiac 18F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds.

Authors:  T Wagner; J Page; M Burniston; A Skillen; J C Ross; R Manwani; D McCool; P N Hawkins; Ashutosh D Wechalekar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-12       Impact factor: 9.236

5.  18F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition.

Authors:  Lucia Baratto; Sonya Youngju Park; Negin Hatami; Praveen Gulaka; Shreyas Vasanawala; Thomas Koshy Yohannan; Robert Herfkens; Ronald Witteles; Andrei Iagaru
Journal:  EJNMMI Res       Date:  2018-07-24       Impact factor: 3.138

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.